Extracellular vesicle glycan profiling for pre-biopsy detection of prostate cancer
Open Access
- 13 August 2026
- journal article
- research article
- Published by Springer Nature in BMC Medicine
- Vol. 24 (1)
Abstract
No abstract availableKeywords
Funding Information
- Cancer Early Detection Advanced Research Center (CEDAR), Knight Cancer Institute at Oregon Health & Science University (Full 2023-1688, Full 2020-1251 and Full 6601019.)
- Cancer Early Detection Advanced Research Center (CEDAR), Knight Cancer Institute at Oregon Health & Science University (Full 2023-1688, Full 2020-1251 and Full 6601019.)
This publication has 36 references indexed in Scilit:
- Development and Validation of an 18-Gene Urine Test for High-Grade Prostate CancerJAMA Oncology, 2024
- Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approachesJournal of Extracellular Vesicles, 2024
- Development of a Whole-urine, Multiplexed, Next-generation RNA-sequencing Assay for Early Detection of Aggressive Prostate CancerEuropean Urology Oncology, 2022
- A 16-yr Follow-up of the European Randomized study of Screening for Prostate CancerEuropean Urology, 2019
- Prostate Magnetic Resonance Imaging Interpretation Varies Substantially Across RadiologistsEuropean Urology Focus, 2019
- A Contemporary Prostate Biopsy Risk Calculator Based on Multiple Heterogeneous CohortsEuropean Urology, 2018
- Bootstrapping the out-of-sample predictions for efficient and accurate cross-validationMachine Learning, 2018
- Prostate-Specific Antigen–Based Screening for Prostate CancerJAMA, 2018
- Systematic Review of Complications of Prostate BiopsyEuropean Urology, 2013
- Increased bisecting N‐acetylglucosamine and decreased branched chain glycans of N‐linked glycoproteins in expressed prostatic secretions associated with prostate cancer progressionProteomics – Clinical Applications, 2013